Both in Pharmaceuticals
Acadia Pharmaceuticals vs Viking Therapeutics
Over the past year ACAD returned −8.0% and VKTX returned −27.5%; their daily moves had a correlation of 0.40.
ACAD −8.0% VKTX −27.5%Growth of $1, one year, split-adjusted
| Metric | ACAD | VKTX |
|---|---|---|
| Price | $20.57 | $26.09 |
| Market cap | $3.54B | $3.33B |
| Today | +0.49% | −2.76% |
| 1 month | +2.3% | −10.9% |
| 6 months | −8.0% | −16.7% |
| Year to date | −23.0% | −25.8% |
| 1 year | −9.4% | −31.5% |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | — |
| Net margin | 10.2% | — |
| P/E (TTM) | 9.3× | — |
| Price / sales | 3.1× | — |
| Net cash | $956.5M | $709.2M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 86.7% |
| Short % of float | 7.1% | 22.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).